Back to search

Endostatin gene therapy enhances the efficacy of paclitaxel to suppress breast cancers and metastases in mice

Data up to Jan 2025

Published2007
Citations16
References60
Clinical Trials (1)

Total Citations Per Year

Abstract

References (60)

Global cancer statistics

2011 • 55,498 citations

Global Cancer Statistics, 2002

2005 • 17,966 citations

Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth

1997 • 4,504 citations

Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy

2001 • 2,069 citations

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.

2000 • 1,536 citations

Hypersensitivity reactions from taxol.

1990 • 1,153 citations

Estrogen and the Risk of Breast Cancer

2001 • 1,081 citations

Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody

1996 • 718 citations

Antiangiogenesis in cancer therapy—endostatin and its mechanisms of action

2005 • 650 citations

Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins

2003 • 473 citations

Evidence for the involvement of endotheliai cell integrin αVβ3 in the disruption of the tumor vascuiature induced by TNF and IFN-γ

1998 • 461 citations

Taxol: Mechanisms of Action and Resistancea

1986 • 415 citations

Endostatin's Antiangiogenic Signaling Network

2004 • 397 citations

Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines.

1998 • 388 citations

Role of Inflammatory Mediators in Angiogenesis

2005 • 275 citations

Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis

2000 • 273 citations

Tumor Cells in Blood Shed From the Surgical Field

1995 • 269 citations

Consequences of angiogenesis for tumor progression, metastasis and cancer therapy

1995 • 243 citations

Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest

1998 • 239 citations

Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells

2001 • 207 citations

Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer

2006 • 207 citations

Antiangiogenesis signals by endostatin

2001 • 198 citations

Endostatin Inhibits Human Tongue Carcinoma Cell Invasion and Intravasation and Blocks the Activation of Matrix Metalloprotease-2, -9, and -13

2003 • 164 citations

Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer

2003 • 157 citations

Gene transfer of antisense hypoxia inducible factor-1 α enhances the therapeutic efficacy of cancer immunotherapy

2001 • 144 citations

Does surgery modify growth kinetics of breast cancer micrometastases?

2001 • 122 citations

Endostatin: The logic of antiangiogenic therapy

2005 • 119 citations

Paclitaxel Enhances Macrophage IL-12 Production in Tumor-Bearing Hosts Through Nitric Oxide

1999 • 114 citations

Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors.

2000 • 95 citations

Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma

2000 • 90 citations

Modelling approaches for angiogenesis

2004 • 89 citations

Synergistic effects of TNF-α and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study

1996 • 87 citations

E-selectin is required for the antiangiogenic activity of endostatin

2004 • 82 citations

Endostatin Exhibits a Direct Antitumor Effect in Addition to Its Antiangiogenic Activity in Colon Cancer Cells

2003 • 71 citations

Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model

2002 • 71 citations

Effects of paclitaxel on cytokine synthesis by unprimed human monocytes, T lymphocytes, and breast cancer cells

1998 • 69 citations

Unfulfilled Promise of Endostatin in a Gene Therapy-Xenotransplant Model of Human Acute Lymphocytic Leukemia

2002 • 59 citations

Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapy

2006 • 58 citations

Continuous Intravascular Secretion of Endostatin in Mice from Transduced Hematopoietic Stem Cells

2002 • 56 citations

Alteration of lymphocyte microtubule assembly, cytotoxicity, and activation by the anticancer drug taxol.

1994 • 51 citations

Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells.

2003 • 47 citations

Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein

2005 • 47 citations

Adeno-Associated Virus–Mediated Delivery of a Mutant Endostatin in Combination with Carboplatin Treatment Inhibits Orthotopic Growth of Ovarian Cancer and Improves Long-term Survival

2006 • 41 citations

Paclitaxel (Taxol) in Breast Cancer

1994 • 40 citations

Inhibition of Cytokine-Induced Microvascular Arrest of Tumor Cells by Recombinant Endostatin Prevents Experimental Hepatic Melanoma Metastasis

2004 • 38 citations

Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production

1997 • 32 citations

Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.

2003 • 32 citations

Antisense integrin αV and β3 gene therapy suppresses subcutaneously implanted hepatocellular carcinomas

2007 • 31 citations

Taxol-mediated changes in fibrosarcoma-induced immune cell function: Modulation of antitumor activities

1997 • 29 citations

Gene transfer of endostatin enhances the efficacy of doxorubicin to suppress human hepatocellular carcinomas in mice

2007 • 29 citations

Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine

2005 • 28 citations

Intramuscular delivery of antiangiogenic genes suppresses secondary metastases after removal of primary tumors

2004 • 28 citations

Low Dose Carboplatin Combined With Angiostatic Agents Prevents Metastasis in Human Testicular Germ Cell Tumor Xenografts

2003 • 28 citations

Concurrent delivery of GM‐CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors

2003 • 23 citations

Increased growth and incidence of lymph node metastases due to the angiogenesis inhibitor AGM-1470

1997 • 21 citations

Immune Response Against 3LL Lewis Lung Carcinoma Potentiates the Therapeutic Efficacy of Endostatin

2001 • 19 citations

Signal transduction mediated by endostatin directly modulates cellular function of lung cancer cells in vitro

2007 • 14 citations

Endostatin Expression by MDA-MB-435 Breast Cancer Cells Effectively Inhibits Tumor Growth

2003 • 12 citations

Electrogene therapy using endostatin, with or without suicide gene therapy, suppresses murine mammary tumor growth and metastasis

2006 • 10 citations

Plasmid DNA-induced cytokines together with cyclophosphamide decrease size and number of melanoma lung metastases.

2006 • 1 citations

Cited By (0)

Loading...
Endostatin gene therapy enhances the efficacy of paclitaxel to suppress breast cancers… (2007) – Journal of Biomedical Science | Metascience Observatory Explorer